About
About Kawasumi Laboratories, Incorporated
Kawasumi Laboratories, Incorporated manufactures and sells medical devices and pharmaceutical products in Japan and internationally. It offers disposable products for hemodialysis treatment, such as dialyzers, blood tubing lines, A.V. fistula needles, and isotonic sodium chloride solutions; products for plasmapheresis that include fractionators and plasma separators; blood collection and transfusion sets comprising blood bags, platelet storage bags, and potassium adsorption filters; winged blood collection sets; and thoracic stent graft systems for endovascular repair. The company was founded in 1954 and is headquartered in Tokyo, Japan. As of September 30, 2020, Kawasumi Laboratories, Incorporated operates as a subsidiary of Sumitomo Bakelite Company Limited.
Visit company website
5 years, 5 months ago
Kawasumi Laboratories, Incorporated is currently in a long term uptrend where the price is trading 45.6% above its 200 day moving average.
From a valuation standpoint, the stock is 97.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.
Based on the above factors, Kawasumi Laboratories, Incorporated gets an overall score of 2/5.